Abstract
Surgical treatment of nonischemic dilated cardiomyopathy is a new field in cardiac surgery. Although current pharmacologic therapy has shown improved survival rates, many patients still need heart transplantation. To reduce the shortage of donors, there is a demanding need for effective nontransplant cardiac surgery. In the past 5 years, partial left ventriculectomy (PLV) has emerged with initial enthusiasm, but is not used because of high surgical mortality and late return of heart failure. There are several examples of improved clinical status and ventricular function with the procedure. By refining patient selection and surgical modification, ventriculoplasty will become a realistic option in the treatment of heart failure caused by nonischemic cardiomyopathy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
